Argitalpenak (119) FRANCISCO COLINA RUIZ-DELGADO argitalpenak

2021

  1. Germline cdh1 g212e missense variant: Combining clinical, in vitro and in vivo strategies to unravel disease Burden

    Cancers, Vol. 13, Núm. 17

2015

  1. Endoscopic submucosal dissection (ESD) of antral subepithelial lesion suspected of malignancy

    Revista Española de Enfermedades Digestivas, Vol. 107, Núm. 6, pp. 380-383

2014

  1. Guía para la interpretación de biopsias endoscópicas con sospecha de enfermedad inflamatoria intestinal idiopática

    Revista Espanola de Patologia

  2. High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice

    DMM Disease Models and Mechanisms, Vol. 7, Núm. 11, pp. 1287-1296

  3. Histologic evaluation of organ preservation injury and correlation with cold ischemia time in 13 intestinal grafts

    Transplantation Proceedings

  4. Histologic evaluation of post-implantation immediate c4d deposition in 13 intestinal grafts: Correlation with cell-based crossmatching, cold ischemia time, and preservation injury

    Transplantation Proceedings

2013

  1. Infliximab-related hepatitis: A case study and literature review

    Digestive Diseases and Sciences, Vol. 58, Núm. 11, pp. 3362-3367

  2. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation

    Transplant Infectious Disease, Vol. 15, Núm. 4, pp. 405-415

2012

  1. Liver transplantation from anti-hepatitis C virus-positive donors: Our experience

    Transplantation Proceedings

2011

  1. Biological behavior due to cell proliferation markers of gastrointestinal stromal tumors

    Hepato-Gastroenterology, Vol. 58, Núm. 105, pp. 76-80

  2. Early-onset colorectal cancer is an easy and effective tool to identify retrospectively Lynch syndrome

    Annals of Surgical Oncology, Vol. 18, Núm. 12, pp. 3285-3291

  3. Switching to sirolimus monotherapy for De Novo tumors after liver transplantation. A preliminary experience

    Hepato-Gastroenterology, Vol. 58, Núm. 105, pp. 115-121

2010

  1. Approach to early-onset colorectal cancer: Clinicopathological, familial, molecular and immunohistochemical characteristics

    World Journal of Gastroenterology, Vol. 16, Núm. 29, pp. 3697-3703

  2. Colorectal cancer prognosis twenty years later

    World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867

  3. Incidencia de segundas neoplasias de naturaleza no hematológica en pacientes con mieloma múltiple

    Revista Clinica Espanola

  4. Prognostic factors in cancer of unknown primary site

    Tumori, Vol. 96, Núm. 1, pp. 111-116

2009

  1. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C

    Liver Transplantation, Vol. 15, Núm. 8, pp. 948-955

2008

  1. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease

    Digestive and Liver Disease, Vol. 40, Núm. 3, pp. 200-205

2007

  1. Relationship between biomarker expression and allelic alteration in esophageal carcinoma

    Journal of Gastroenterology and Hepatology (Australia), Vol. 22, Núm. 12, pp. 2303-2309

2006

  1. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation

    Liver Transplantation, Vol. 12, Núm. 12, pp. 1805-1812